Showing Results : 1-1 of 1
Sort By :


  • Frontiers in Pharmacology: 2023, vol: 14, issue:
  • 1)- Leyi Zhang, Xing Huang, Yonghong Gao, Xiangyu Li, Qiao Kong, Ying Chen, Jingling Chang, Genming Zhang, Yan Ma. Herbal formulas for detoxification and dredging collaterals in treating carotid atherosclerosis: a systematic review and meta-analysis. Frontiers in pharmacology. 2023, 14: 1147964
    Cited : 2
    Read More
  • 2)- Liuting Zeng, Qi He, Ying Deng, Yuwei Li, Junpeng Chen, Kailin Yang, Yanfang Luo, Anqi Ge, Xiaofei Zhu, Zhiyong Long, Lingyun Sun. Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials. Frontiers in pharmacology. 2023, 14: 1189142
    Cited : 1
    Read More
  • 3)- Kun Zhang, Hengxing Gao, Mingwei Chen. Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study. Frontiers in pharmacology. 2023, 14: 1224737
    Cited : 0
    Read More
  • 4)- Min-Woo Song, Wenhao Cui, Chang-Gun Lee, Rihua Cui, Young Ho Son, Young Ha Kim, Yujin Kim, Hae Jin Kim, Sung-E Choi, Yup Kang, Tae Ho Kim, Ja Young Jeon, Kwan-Woo Lee. Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells. Frontiers in pharmacology. 2023, 14: 1228646
    Cited : 2
    Read More
  • 5)- Jing Chang, Jiahui Wang, Beibei Luo, Weihao Li, Ziyue Xiong, Chaoqi Du, Xue Wang, Yuejiao Wang, Jingya Tian, Shuxin Li, Yue Fang, Longjie Li, Jing Dong, Ke Tan, Yumei Fan, Pengxiu Cao. Vitamin E stabilizes iron and mitochondrial metabolism in pulmonary fibrosis. Frontiers in pharmacology. 2023, 14: 1240829
    Cited : 2
    Read More
  • 6)- Jinyu Zhao, Liang Tian, Bin Xia, Ningning Mi, Qiangsheng He, Man Yang, Danni Wang, Siqing Wu, Zijun Li, Shiyong Zhang, Xianzhuo Zhang, Ping Yue, Yanyan Lin, Haitong Zhao, Baoping Zhang, Zelong Ma, Ningzu Jiang, Matu Li, Jinqiu Yuan, Peng Nie, Linzhi Lu, Wenbo Meng. Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study. Frontiers in pharmacology. 2023, 14: 1244563
    Cited : 1
    Read More
  • 7)- Yi-Hsin Chen, Chih-Tsung Chen, Han-Ping Wu. Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study. Frontiers in pharmacology. 2023, 14: 1260683
    Cited : 1
    Read More
  • 8)- Tesfay Mehari Atey, Gregory M Peterson, Mohammed S Salahudeen, Tom Simpson, Camille M Boland, Ed Anderson, Barbara C Wimmer. Clinical and economic impact of partnered pharmacist medication charting in the emergency department. Frontiers in pharmacology. 2023, 14: 1273657
    Cited : 1
    Read More
  • 9)- Eric Fordjour, Charles F Manful, Rabia Javed, Lakshman W Galagedara, Chad W Cuss, Mumtaz Cheema, Raymond Thomas. Chaga mushroom: a super-fungus with countless facets and untapped potential. Frontiers in pharmacology. 2023, 14: 1273786
    Cited : 2
    Read More
  • 10)- Mrittika Roy, Shaifali Saroha, Uddipan Sarma, Harini Sarathy, Rukmini Kumar. Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease. Frontiers in pharmacology. 2023, 14: 1274490
    Cited : 0
    Read More
  • 11)- Liangtao Wen, Lixiang Xie, Fengying Gong, Shunan Zhang, Tieju Xi. Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis. Frontiers in pharmacology. 2023, 14: 1277284
    Cited : 2
    Read More
  • 12)- Huqun Li, Chongshu Wang, Aiping Deng, Cuilian Guo. A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system. Frontiers in pharmacology. 2023, 14: 1280490
    Cited : 0
    Read More
  • 13)- Jia-Jia Huang, Ji-Zhen Cai, Zhi-Peng Zhou, Yan Liu, Zhen-Jia Yang, Da-Zheng Li, Yu-Hua Chen, Ying-Yi Luan, Yong-Ming Yao, Ming Wu. Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse. Frontiers in pharmacology. 2023, 14: 1281235
    Cited : 1
    Read More
  • 14)- Getnet Tadege, Betelhem Sirak, Dehnnet Abebe, Dejen Nureye. Antinociceptive and antiinflammatory activities of crude leave extract and solvent fractions of Hochst. ex C.B.Clarke (Commelinaceae) leaves in murine model. Frontiers in pharmacology. 2023, 14: 1284087
    Cited : 1
    Read More
  • 15)- Xue Zhong, Chao Wang, Lin Huang, Yue Zhao, Tianyi Li, Jing He, Xiaohong Zhang. Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study. Frontiers in pharmacology. 2023, 14: 1288402
    Cited : 0
    Read More
  • 16)- Siti Liyana Saud Gany, Kok-Yong Chin, Jen Kit Tan, Amilia Aminuddin, Suzana Makpol. Preventative and therapeutic potential of tocotrienols on musculoskeletal diseases in ageing. Frontiers in pharmacology. 2023, 14: 1290721
    Cited : 1
    Read More
  • 17)- Susanne Jacobsson, Daniel Golparian, Joakim Oxelbark, Fabian Y S Kong, Renata Maria Augusto Da Costa, Francois Franceschi, David Brown, Arnold Louie, George Drusano, Magnus Unemo. Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against in a gonococcal hollow-fiber infection model. Frontiers in pharmacology. 2023, 14: 1291885
    Cited : 4
    Read More
  • 18)- Ni Zhou, Shanshan Wei, Taoli Sun, Suifen Xie, Jian Liu, Wenqun Li, Bikui Zhang. Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. Frontiers in pharmacology. 2023, 14: 1292088
    Cited : 5
    Read More
  • 19)- Leonie Zurfluh, Marialuigia Giovannini Spinelli, Cornelia Betschart, Ana Paula Simões-Wüst. Repurposing of for dysmenorrhea treatment: a systematic scoping review and case series. Frontiers in pharmacology. 2023, 14: 1292919
    Cited : 1
    Read More
  • 20)- Jacqueline Knapke, Michelle Marcum, Angela Mendell, Patrick Ryan. Development of an undergraduate certificate in clinical and translational science: improving competence of the clinical research workforce. Frontiers in pharmacology. 2023, 14: 1294534
    Cited : 0
    Read More
  • 21)- Amin Yakubov, Dina Pimenova, Alzahraa Ahmed, Romelia Corvacho, Joanna Madigan, Jay Naik, Chen Lyu, Anita McFarlane, Victoria Foster, Megan Haseltine, Alexandr Trifonov, Ivette Cabrera, Clarissa Rios, Rachel Gross, Melanie Jay, Aaron Lord, Gabrielle Gold-von Simson, Brita Roy, Amy Freeman, Nadia Islam, James Holahan. The development of a clinical research educational training for community health workers using the joint task force for clinical trial competency framework. Frontiers in pharmacology. 2023, 14: 1295281
    Cited : 1
    Read More
  • 22)- Qian Chen, Qingqing Wu, Rong Song, Yating Wang, Mengqi Zhang, Fangqiong Li, Weifang Zeng, Wei Wang, Jingying Jia, Chen Yu, Yanmei Liu. A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects. Frontiers in pharmacology. 2023, 14: 1296672
    Cited : 0
    Read More
  • 23)- Tingting Jin, Wei Xu, Roufen Chen, Liteng Shen, Jian Gao, Lei Xu, Xinglong Chi, Nengming Lin, Lixin Zhou, Zheyuan Shen, Bo Zhang. Discovery of potential WEE1 inhibitors via hybrid virtual screening. Frontiers in pharmacology. 2023, 14: 1298245
    Cited : 1
    Read More
  • 24)- Alessia Greco, Francesca Coperchini, Laura Croce, Flavia Magri, Marsida Teliti, Mario Rotondi. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs. Frontiers in pharmacology. 2023, 14: 1303844
    Cited : 3
    Read More
  • 25)- Judong Kim, Fei Qiao, Avtar K Singh, Jeseong Won, Inderjit Singh. Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice. Frontiers in pharmacology. 2023, 14: 1304697
    Cited : 2
    Read More
  • 26)- Sandra Truong, Poonam Mudgil. The antibacterial effectiveness of lavender essential oil against methicillin-resistant : a systematic review. Frontiers in pharmacology. 2023, 14: 1306003
    Cited : 3
    Read More
  • 27)- Zhenyu Liu, Kexin Yin, Huiqian Liu, Ning Wang, Junjie Yao, Jiangtao Zhou, Yongxi Tang, Zhikang Yin. Comparison of a novel tablet formulation of tacrolimus and conventional capsule formulation in kidney transplant recipients: a systematic review and meta-analysis. Frontiers in pharmacology. 2023, 14: 1310339
    Cited : 0
    Read More
  • 28)- Lydia Bisbal Lopez, Domenico Ravazza, Matilde Bocci, Aureliano Zana, Lucrezia Principi, Sheila Dakhel Plaza, Andrea Galbiati, Ettore Gilardoni, Jörg Scheuermann, Dario Neri, Luca Pignataro, Cesare Gennari, Samuele Cazzamalli, Alberto Dal Corso. mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker. Frontiers in pharmacology. 2023, 14: 1320524
    Cited : 2
    Read More
  • 29)- Awaji Y Safhi, Nimbagal Raghavendra Naveen, Krishna Jayanth Rolla, Penmetsa Durga Bhavani, Mallesh Kurakula, Khaled M Hosny, Walaa A Abualsunun, Mohammed Alissa, Abdullah Alsalhi, Amerh Aiad Alahmadi, Khalid Zoghebi, Abdulrahman Sindam Halwaani, Rasha Ibrahim K. Enhancement of antifungal activity and transdermal delivery of 5-flucytosine via tailored spanlastic nanovesicles: statistical optimization, characterization, and biodistribution study. Frontiers in pharmacology. 2023, 14: 1321517
    Cited : 1
    Read More
  • 30)- Alan Jhones Barbosa Assis, Brunna Letícia de Oliveira Santana, Ana Cristina Moura Gualberto, Fabio Pittella-Silva. Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications. Frontiers in pharmacology. 2023, 14: 1322937
    Cited : 1
    Read More
  • 31)- Xinqiang Liang, Yanping Tang, Mekhrdod S Kurboniyon, Danni Luo, Guiwan Tu, Pengle Xia, Shufang Ning, Litu Zhang, Chen Wang. PdMo nanoflowers for endogenous/exogenous-stimulated nanocatalytic therapy. Frontiers in pharmacology. 2023, 14: 1324764
    Cited : 0
    Read More
  • 32)- Hamid Saeed Shah, Sumera Zaib, Imtiaz Khan, Mahmoud A Sliem, Osama Alharbi, Mohammed Al-Ghorbani, Zobia Jawad, Kiran Shahzadi, Sajjad Awan. Preparation and investigation of a novel combination of loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: , , and evaluation. Frontiers in pharmacology. 2023, 14: 1325498
    Cited : 1
    Read More
  • 33)- Zhenglin He, Yihan Wang, Liang Han, Yue Hu, Xianling Cong. The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases. Frontiers in pharmacology. 2023, 14: 1330518
    Cited : 3
    Read More
  • 34)- Jin Xiao, Yan-Ni Zhou, Yan-Lin Yang, Li He, Ke-Kai Wang, Min Chen. Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis. Frontiers in pharmacology. 2023, 14: 1330698
    Cited : 0
    Read More
  • 35)- Hong Zhou, Yan Kang, Daolin Tang, Lefu Lan. Editorial: Sepsis: basic, clinical and therapeutic approaches, volume II. Frontiers in pharmacology. 2023, 14: 1339116
    Cited : 0
    Read More
  • 36)- Serena Di Vincenzo, Maria Ferraro, Maria Letizia Manca, Josè Esteban Peris, Elisabetta Pace. Editorial: Novel therapeutic strategies for the treatment of respiratory diseases. Frontiers in pharmacology. 2023, 14: 1340116
    Cited : 0
    Read More
  • 37)- Giada Crescioli, Niccolò Lombardi, Alfredo Vannacci. Editorial: Safety of drugs and CAM products in pregnancy and breastfeeding: evidence from clinical toxicology. Frontiers in pharmacology. 2023, 14: 1340283
    Cited : 1
    Read More
  • 38)- Mengya Chen, Saiyang Xie, Wei Deng. Editorial: Molecular mechanism and pharmacology of metabolism and cardiac remodeling. Frontiers in pharmacology. 2023, 14: 1341004
    Cited : 0
    Read More
  • 39)- Paola Patrignani, Nils Helge Schebb, Oliver Werz, Dieter Steinhilber. Editorial: Lipidomics of oxylipins in biological systems. Frontiers in pharmacology. 2023, 14: 1342596
    Cited : 0
    Read More
  • 40)- Andrea Cruz, Elisabete Fernandes, Raquel O Rodrigues, Susana O Catarino, Diana Pinho. Editorial: Disease-on-a-chip: from point-of-care to personalized medicine. Frontiers in pharmacology. 2023, 14: 1344379
    Cited : 0
    Read More
  • 41)- . Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin. Frontiers in pharmacology. 2023, 14: 1349235
    Cited : 0
    Read More
 
 


Journal List
Links
Content Links
About Us

0